Compare Enveric Biosciences Inc (ENVB) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Honeywell International Inc — how do they compare? Enveric Biosciences Inc trades at $1.32 (market cap $5.32M), while Honeywell International Inc trades at $222 (market cap $70.60B). The key difference: Honeywell International Inc is far larger — about 13270.7× Enveric Biosciences Inc's market cap, and Honeywell International Inc pays a 4.27% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | HON | |
|---|---|---|
Market Cap | $5.32M | $70.60B |
Sector | Health | Industrials |
52-Week High | $17.40 | $248.04 |
52-Week Low | $1.28 | $188.14 |
Enterprise Value | $408.82K | $94.95B |
Dividend Yield | — | 4.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Honeywell Technologies (HON) trades at $222.68, showing modest daily gains of 0.19%. The stock recently completed a 2:1 reverse stock split on June 29, 2026, and updated its 2026 EPS guidance accordingly. Technically, the stock faces immediate resistance at $224 with support at $222, while the broader technical signal remains bearish. Fundamentally, the company reported three consecutive quarterly earnings beats, with Q1 2026 EPS of $2.58 beating expectations of $2.43. However, revenue declined slightly from $38.5B in 2024 to $37.4B in 2025, and net income margins compressed from 14.81% to 12.63% over the same period.
The investment outlook presents a mixed picture. Analyst consensus remains strongly bullish with 19 buy ratings and a $368.55 price target, representing 65% upside potential. However, near-term challenges include weaker process automation performance, post-spinoff execution uncertainty, and margin pressure. The company's renewed focus on automation and industrial technology post-aerospace spinoff offers long-term growth potential, but investors face transitional volatility and integration risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
